Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 170 citing Shafer: Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance.... (0.10 sec) 

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed …

- bms.com.ve [PDF] 
J Durant, P Clevenbergh, P Halfon, P Delgiudice, S … - The Lancet, 1999 - Elsevier
108 patients were enrolled. All patients were similar for risk factors, age, sex, previous
treatment, CD4-cell count (214/fxL [SD14]) and log HIV-1 RNA viral load at baseline (4–7
copies/ml [0–1]). At month 3, the mean change in HIV-1 RNA was -1-04 log (0–14) in the ...
Cited by 728 - Related articles - BL Direct - All 14 versions

HIV-1 drug resistance in newly infected individuals


D Boden, A Hurley, L Zhang, Y Cao, Y Guo, E Jones, J … - Jama, 1999 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context There is concern that the widespread use ...
Cited by 460 - Related articles - BL Direct - All 4 versions

Human immunodeficiency virus reverse transcriptase and protease sequence …

- nih.gov
RW Shafer, D Stevenson, B Chan - Nucleic acids research, 1999 - Oxford Univ Press
The HIV RT and Protease Sequence Database is an on-line relational database that catalogues
evolutionary and drug-related human immunodeficiency virus reverse transcriptase (RT) and
protease sequence variation (http://hivdb.stanford.edu ). The database contains a ...
Cited by 341 - Related articles - BL Direct - All 25 versions

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir …


DV Havlir, NS Hellmann, CJ Petropoulos, JM Whitcomb … - Jama, 2000 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Loss of viral suppression in patients ...
Cited by 318 - Related articles - BL Direct - All 3 versions

Predictors of self-reported adherence and plasma HIV concentrations in patients …


AL Gifford, JE Bormann, MJ Shively, BC … - JAIDS Journal of …, 2000 - journals.lww.com
*†Allen L. Gifford, *†Jill E. Bormann, *‡Martha J. Shively, *†Brian C. Wright, *†Douglas D.
Richman, and *†§Samuel A. Bozzette ... *Health Services Research and Development, VA San
Diego Healthcare System, San Diego; †University of California San Diego School of ...
Cited by 307 - Related articles - BL Direct - All 9 versions

HIV drug resistance

- pu.ru [PDF] 
F Clavel, AJ Hance - The New England journal of medicine, 2004 - nejm.org
The use of combinations of antiretroviral drugs has proven remarkably effective in controlling
the progression of human immunodeficiency virus (HIV) disease and prolonging survival, 1 but
these benefits can be compromised by the development of drug resistance. 2 , 3 ...
Cited by 289 - Related articles - All 12 versions

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir …

- annals.org [PDF] 
AR Zolopa, RW Shafer, A Warford, JG … - Annals of internal …, 1999 - Am Coll Physicians
Andrew R. Zolopa, MD; Robert W. Shafer, MD; Ann Warford, PhD; Jose G. Montoya, MD; Phillip
Hsu, BA; David Katzenstein, MD; Thomas C. Merigan, MD; and Brad Efron, PhD ...
Background: Tests for resistance to HIV drugs are avail- able for clinical use; however, ...
Cited by 208 - Related articles - All 11 versions

Genotypic testing for human immunodeficiency virus type 1 drug resistance

- nih.gov
RW Shafer - Clinical Microbiology Reviews, 2002 - cmr.highwire.org
There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs belonging to three
mechanistic classes: protease inhibitors, nucleoside and nucleotide reverse transcriptase
(RT) inhibitors, and nonnucleoside RT inhibitors. HIV-1 resistance to these drugs is ...
Cited by 199 - Related articles - BL Direct - All 12 versions

Predictors of optimal virological response to potent antiretroviral therapy


WG Powderly, MS Saag, S Chapman, G Yu, B Quart, … - Aids, 1999 - journals.lww.com
Skip Navigation Links Home > October 1, 1999 - Volume 13 - Issue 14 > Predictors of optimal
virological response to potent antiret... ... Powderly, William G.; Saag, Michael S.; Chapman,
Sharon; Yu, George; Quart, Barry; Clendeninn, Neil J. ... From the Washington University ...
Cited by 187 - Related articles - BL Direct - All 4 versions

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after …


JL Meynard, M Vray, L Morand-Joubert, E Race, D … - Aids, 2002 - journals.lww.com
Skip Navigation Links Home > March 29, 2002 - Volume 16 - Issue 5 > Phenotypic or genotypic
resistance testing for choosing anti... ... From the Hôpital Saint-Antoine, a INSERM SC4, b Hôpital
Bichat Claude Bernard, and c Hôpital Rothschild, Paris, France. *See Cited Here....
Cited by 181 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google